Previously dismissed as "junk DNA," the non-coding 98% of the genome is actually the information processing core. It's where epigenetics happens, allowing our genome to respond to the environment, and it's where most genetic risk for chronic diseases is found.

AI isn't just for designing RNA sequences. Its real value is in creating predictive models of complex cellular functions. This allows scientists to determine the precise set of instructions (RNAs) needed to make a cell perform a complex series of tasks, like targeting a brain tumor.

Mitochondria in different organs are not identical. Despite sharing the same genes, they differentiate into specialized "mitotypes" with distinct forms and functions, analogous to worker and warrior ants. This cellular division of labor is crucial for organ-specific energy needs.

Beyond DNA screening, future diagnostics could analyze RNA in sperm and eggs. Since RNA profiles are plastic and can be influenced by lifestyle (e.g., exercise), this could allow for 'correcting' harmful epigenetic inheritance patterns before conception, a level of intervention impossible with fixed DNA.

Contrary to popular belief, less than 1% of diseases are linked to genes. Genes don't control their own expression; they are blueprints. The mind, through the science of epigenetics, acts as the architect, selecting and modifying which genetic blueprints are activated, making us creators of our health, not victims.

Dr. Michael Levin argues that DNA specifies cellular hardware, but bioelectric patterns act as reprogrammable software that stores anatomical memories. This software can be rewritten to produce radical changes, like two-headed worms, without altering the genetic code, challenging the DNA-centric view of biology.

Two people with the same cancer type respond differently to drugs because cancer is driven by accumulating errors in a cell's 'computer code.' A drug might work for one patient but fail in another whose cancer cells have developed an additional 'error' that confers resistance.

Genomic data (DNA) provides a static blueprint of potential, not a view of the actual biological activity. True understanding requires measuring the dynamic interactions of molecules and cells within tissues "downstream." Current methods capture only fragmentary slices, missing the full picture.

While DNA is largely fixed, small RNA molecules are emerging as a key mechanism for transgenerational inheritance. These RNAs can carry information from a parent's experience—such as exposure to a virus—and directly influence gene expression and traits in their offspring, bypassing traditional genetic pathways.